Mexico City /
The National Council of Science and Technology (Conacyt) continues to look for volunteers for the phase 2 clinical study, whose objective is evaluate the use of the Mexican vaccine Patria against covid-19 developed together with the Avimex laboratory, as a reinforcement in people who have been previously vaccinated.
“The participation of the volunteers is vital for the Mexican Patria vaccine to become a reality, a solidarity effort of the people, for the benefit of the people, with which a firm step is taken towards scientific sovereignty and the recovery of the national vaccine industry” , indicates a video released by Conacyt.
What does the homeland vaccine trial consist of?
The participation of the volunteers consists of going to the facilities of the research site during the time in which the clinical study is carried out, During these visits, monitoring of the health status of each of the participants will be carried out., laboratory samples will be taken, PCR samples, blood pressure control and oxygen levels will be carried out to know the body’s response to the vaccine.
Around 400 people will participate. half will be vaccinated and the other half will receive a placebo, which is a substance that lacks an active ingredient, the members of this second group will receive the reinforcement weeks later with the vaccines already authorized in Mexico.
What are the advantages of participating in the national vaccine trial?
Conacyt highlighted a series of advantages when participating in this clinical study:
- Medical expenses insurance.
- Constant monitoring of health status.
- Medical studies: electrocardiogram, blood pressure, oxygen levels and laboratory tests that include glucose, triglyceride and cholesterol levels.
- PCR test at each visit.
- Support of 500 pesos for travel expenses.
How can I participate in the homeland vaccine trial?
All persons over 18 years of age, residents of Mexico City who check have received a complete schedule of vaccinations Pfizer, CanSino (one dose), Sinovac, Johnson & Johnson (one dose), AstraZeneca, Sputnik, and Moderna, at least four months before participating in the study.
- In addition to meeting the following requirements:
- Not having presented respiratory diseases during the last 21 days.
- Not be pregnant or lactating.
- Have good general health.
- Not be participating in another clinical study protocol
- In case of presenting any chronic disease, the volunteer participants must verify that it is controlled and under medical supervision; stable and without changes in treatment during the last three months.
Once accepted, the participants will receive a consent form to participate in the clinical study and will receive detailed information about it. It should be noted that the study will last one year; During this period, the participants will be followed up with face-to-face visits and telephone calls.
For more information, it is suggested to call the following telephone numbers, from 9:00 a.m. to 6:00 p.m. and from Monday to Friday: 5565834651, 5567321794 and 5591065114.
JLMR
–
–
